NCT05314621 - A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

July 24, 2022

Study Completion Date

July 24, 2022

Conditions

Allergic Conjunctivitis

Interventions

DRUG

olopatadine hydrochloride ophthalmic solution 0.7%)

Pataday® Once Daily Relief Extra Strength (eyedrop)

DRUG

Fluticasone Propionate

Flonase® Allergy Relief (nasal spray)

DRUG

Tears Naturale

Tears Naturale® II (eye drop)

DRUG

Saline nasal spray

Saline nasal spray (nasal spray)

Trial Locations (1)

Andover Eye Associates, Andover